Arrhythmia Market Analysis By Site Of Origin Atrial (Sinus Bradycardia, Premature Atrial contractions (PACs), Wandering Atrial Pacemaker, Atrial tachycardia), By Test Equipment (Electrocardiogram (ECG), Holter monitor), And Segment Forecasts, 2014 To 2025

Arrhythmia is an abnormal heart rhythm. It may feel like fluttering or a brief pause. It may be so brief that it does not change your overall heart rate (the number of times per minute that your heart beats), or it can cause the heart rate to be too slow or too fast.

Some arrhythmias do not cause any symptoms. Others can make you feel dizzy. Also, Cardiac arrhythmia is termed as “cardiac dysrhythmia” or “irregular heartbeat”. It is a group of conditions wherein the heartbeat is irregular, too fast, or too slow.

A heart rate that is too fast; i.e. above 100 beats per minute in adults is called “tachycardia” and a heart rate that is too slow; i.e. below 60 beats per minute is called “bradycardia”. Many types of arrhythmia have no symptoms. When symptoms are present these may include palpitations or feeling a pause between heartbeats.

Factors such as a growing global number of cases of lifestyle habits such as smoking, excessive alcohol consumption, and obesity (which makes a person more susceptible to cardiac arrhythmias), and rising patient awareness levels are driving the growth of this market.

The other driving factors are growing consumption of tobacco and alcohol, accelerating economic growth, rising obese population, rising healthcare expenditure, rise of irrigated RF ablation catheter devices, emerging market adoption to increase sale, primary prevention on the rise globally, and increasing prevalence of cardiac arrhythmias.

Arrhythmia Market is segmented on the basis of Types of Arrhythmia as Extra beats: Extra beats include premature arterial contractions and premature ventricular contractions and premature ventricular contractions; Supraventicular tachycardias: Supraventicular tachycardias include ventricular fibrillation and ventricular tachycardia;  Ventricular arrhythmias: It includes ventricular fibrillation and ventricular tachycardia; and bradyarrhythmias: Although a heart rate below 60 beats a minute while at rest is considered bradycardia, low resting heart rate does not always signal a problem.

If an individual is physically fit, he/she may have an efficient heart capable of pumping an adequate supply of blood with fewer than 60 beats a minute while rest. Arrhythmias are due to problems with the electrical conduction system of the heart. Arrhythmias may occur in children. However, the normal range for the heart rate is different and depends on age.

Arrhythmia Market is segmented on the basis of Test Equipment which can help with diagnosis: Electrocardiogram (ECG) and Holter monitor.

Arrhythmia Market is segmented on the basis of Site of Origin: Atrial into Sinus bradycardia, Premature atrial contractions (PACs), Wandering atrial pacemaker, Atrial tachycardia, Multifocal atrial tachycardia, Supraventricular tachycardia (SVT), Atrial flutter, Atrial fibrillation (Afib).

Arrhythmia Market is segmented on the basis of Hearth blocks as follows:

These are also known as AV blocks; because the vast majority of them arise from pathology at the atrioventricular node. They are the most common causes of bradycardia:

First degree heart block: This manifests as PR prolongation.

Second degree heart block: Type 1 Second degree heart block, also known as Mobitz I, Type 2 Second degree heart block, also known as Mobitz II, Third degree heart block, also known as complete heart block.

Third Degree heart block:

This is referred to as senatorial block typically manifesting with various degrees and patterns of sinus bradycardia.

Arrhythmia Market is segmented on the basis of Geographical Region into North America, Europe, Asia-Pacific, and RoW.

In the Asia Pacific region and South American regions, an increasing population of patients with cardiac arrhythmias and congestive heart failure (CHF) conditions is expected to drive demand in the future.

High unmet medical needs coupled with constantly improving healthcare infrastructure in emerging Asian and Latin American regions are expected to drive the market exponentially.

Arrhythmia Market Major Players: Boston Scientific, Medtronic Inc., St. Jude Medical